Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Brooke Bernhardt"'
Autor:
Mark Zobeck, M. Brooke Bernhardt, Kala Y. Kamdar, Karen R. Rabin, Philip J. Lupo, Michael E. Scheurer
Publikováno v:
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 43:205-214
Autor:
Rachel D. Harris, Melanie Brooke Bernhardt, Mark C. Zobeck, Olga A. Taylor, Maria Monica Gramatges, Eric S. Schafer, Philip J. Lupo, Karen R. Rabin, Michael E. Scheurer, Austin L. Brown
Publikováno v:
Cancer. 129:1287-1294
Autor:
Olive S. Eckstein, M. Brooke Bernhardt, Chelsey G. Hood, Vivekanudeep Karri, Stephen F. Kralik, Kenneth L. McClain
Publikováno v:
Pediatric Hematology and Oncology. :1-9
Autor:
Priyadarshani Dharia, Michael D. Swartz, M. Brooke Bernhardt, Han Chen, M. Monica Gramatges, Philip J. Lupo, Austin L. Brown, Michael E. Scheurer
Publikováno v:
Leukemia & Lymphoma. 63:2948-2954
A total of 548 patients (age range: 1-22 years, 60.4% Hispanic, 55.8% male) diagnosed with acute lymphoblastic leukemia were reviewed for pegaspargase-associated hypersensitivity (14.8%), hyperbilirubinemia (9.7%), venous thromboembolism (VTE, 9.7%),
Autor:
Sterre Schoon, Nthongase Makamo, Aniek Uittenboogaard, Brooke Bernhardt, Nmazuo Ozuah, Gertjan Kaspers, Minke Huibers
Objectives This systematic review provides an overview of the effect of malnutrition on the pharmacokinetics of chemotherapy in children with cancer. Methods PubMed, Embase and Cochrane were searched to identify eligible studies. Malnutrition was ref
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6bba4be5b9de8b7bab96c728fdbdbeab
https://doi.org/10.22541/au.167601090.09861210/v1
https://doi.org/10.22541/au.167601090.09861210/v1
Autor:
Carlos Rodriguez-Galindo, Abha A. Gupta, Yueh Yun Chi, Douglas S. Hawkins, M. Fatih Okcu, Heidi V. Russell, M. Brooke Bernhardt
Publikováno v:
Cancer. 128:317-325
Background The Children's Oncology Group clinical trial for intermediate risk rhabdomyosarcoma randomized participants to a combination of vincristine, dactinomycin, and cyclophosphamide (VAC) alone or VAC alternating with vincristine plus irinotecan
Autor:
M. Brooke Bernhardt, Austin L. Brown, Austyn T. Grim, Michael E. Scheurer, Nader Kim El‐Mallawany, Nmazuo W. Ozuah
Publikováno v:
Pediatric Blood & Cancer. 69
High-dose methotrexate (HD-MTX) with rigorous supportive care is essential to the treatment of pediatric non-Hodgkin lymphomas (NHL). We describe the safety and tolerability of HD-MTX in patients with NHL treated at our center. In our cohort of 46 pa
Autor:
Tamara P. Miller, Nicholas P. DeGroote, Zachary Taylor, Lauren Pommert, Oluwafunbi Awoniyi, Sarah Board, Ngozi Ugboh, Vivek Joshi, Allison Weisnicht, Nicholas Ambrosino, Melanie Brooke Bernhardt, Eric S Schafer, Maureen M. O'Brien, Sharon M. Castellino, Laura B. Ramsey
Publikováno v:
Blood. 140:2185-2186
Autor:
Adam J. Lamble, Xiaowei Liu, Charles Minard, Olga Militano, Melanie Brooke Bernhardt, Todd M. Cooper, Edward A. Kolb, Erin H. Breese, Elizabeth Fox, Sarah K Tasian, Brenda J. Weigel
Publikováno v:
Blood. 140:6209-6210
Autor:
Yoram Unguru, Melanie Brooke Bernhardt, Stacey L Berg, Liza Marie-Johnson, Kim Pyke Grimm, Catherine Woodman, Conrad V Fernandez
Publikováno v:
The Lancet Oncology. 24:e67